Hisamitsu Pharmaceutical Co., Inc. (TYO: 4530)
Japan
· Delayed Price · Currency is JPY 4,368.00
-7.00 (-0.16%)
Nov 12, 2024, 3:45 PM JST
Hisamitsu Pharmaceutical Co. Income Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2019 - 2015 |
| Revenue | 150,185 | 141,706 | 128,330 | 120,193 | 114,510 | 140,992 | Upgrade
|
| Revenue Growth (YoY) | 10.68% | 10.42% | 6.77% | 4.96% | -18.78% | -1.68% | Upgrade
|
| Cost of Revenue | 65,452 | 62,735 | 55,630 | 50,126 | 45,337 | 53,388 | Upgrade
|
| Gross Profit | 84,733 | 78,971 | 72,700 | 70,067 | 69,173 | 87,604 | Upgrade
|
| Selling, General & Admin | 62,309 | 57,157 | 51,282 | 50,125 | 47,762 | 54,316 | Upgrade
|
| Research & Development | 8,614 | 8,614 | 9,785 | 10,613 | 10,766 | 10,504 | Upgrade
|
| Operating Expenses | 70,955 | 65,803 | 61,099 | 60,730 | 58,501 | 64,875 | Upgrade
|
| Operating Income | 13,778 | 13,168 | 11,601 | 9,337 | 10,672 | 22,729 | Upgrade
|
| Interest Expense | -27 | -18 | -15 | -20 | -10 | -19 | Upgrade
|
| Interest & Investment Income | 4,098 | 3,684 | 1,872 | 1,058 | 1,406 | 1,953 | Upgrade
|
| Earnings From Equity Investments | 470 | 585 | 424 | 569 | 133 | 786 | Upgrade
|
| Currency Exchange Gain (Loss) | -109 | 1,778 | 1,973 | 1,276 | -542 | -149 | Upgrade
|
| Other Non Operating Income (Expenses) | 586 | 450 | 195 | 417 | 169 | 329 | Upgrade
|
| EBT Excluding Unusual Items | 18,796 | 19,647 | 16,050 | 12,637 | 11,828 | 25,629 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2,692 | 389 | -257 | 653 | 188 | -176 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6 | -6 | 320 | -55 | 178 | 46 | Upgrade
|
| Asset Writedown | -847 | -847 | - | - | - | -953 | Upgrade
|
| Other Unusual Items | 1 | 1 | -1 | -280 | 2 | 1,609 | Upgrade
|
| Pretax Income | 20,648 | 19,184 | 16,112 | 12,955 | 12,196 | 26,155 | Upgrade
|
| Income Tax Expense | 5,487 | 4,754 | 3,987 | 3,093 | 2,764 | 7,244 | Upgrade
|
| Earnings From Continuing Operations | 15,161 | 14,430 | 12,125 | 9,862 | 9,432 | 18,911 | Upgrade
|
| Minority Interest in Earnings | -511 | -461 | -383 | -204 | -182 | -217 | Upgrade
|
| Net Income | 14,650 | 13,969 | 11,742 | 9,658 | 9,250 | 18,694 | Upgrade
|
| Net Income to Common | 14,650 | 13,969 | 11,742 | 9,658 | 9,250 | 18,694 | Upgrade
|
| Net Income Growth | 7.29% | 18.97% | 21.58% | 4.41% | -50.52% | -2.66% | Upgrade
|
| Shares Outstanding (Basic) | 75 | 77 | 79 | 81 | 82 | 82 | Upgrade
|
| Shares Outstanding (Diluted) | 75 | 77 | 79 | 81 | 82 | 82 | Upgrade
|
| Shares Change (YoY) | -4.02% | -3.03% | -2.29% | -0.63% | -0.56% | -1.56% | Upgrade
|
| EPS (Basic) | 194.97 | 181.61 | 148.00 | 118.92 | 113.21 | 227.58 | Upgrade
|
| EPS (Diluted) | 194.73 | 181.42 | 147.88 | 118.84 | 113.11 | 227.30 | Upgrade
|
| EPS Growth | 11.79% | 22.68% | 24.44% | 5.07% | -50.24% | -1.11% | Upgrade
|
| Free Cash Flow | 314 | 5,264 | 4,868 | 15,589 | 1,948 | 23,697 | Upgrade
|
| Free Cash Flow Per Share | 4.17 | 68.36 | 61.31 | 191.82 | 23.82 | 288.13 | Upgrade
|
| Dividend Per Share | 128.000 | 85.000 | 84.000 | 84.000 | 83.500 | 83.000 | Upgrade
|
| Dividend Growth | 204.76% | 1.19% | 0% | 0.60% | 0.60% | 0.61% | Upgrade
|
| Gross Margin | 56.42% | 55.73% | 56.65% | 58.30% | 60.41% | 62.13% | Upgrade
|
| Operating Margin | 9.17% | 9.29% | 9.04% | 7.77% | 9.32% | 16.12% | Upgrade
|
| Profit Margin | 9.75% | 9.86% | 9.15% | 8.04% | 8.08% | 13.26% | Upgrade
|
| Free Cash Flow Margin | 0.21% | 3.71% | 3.79% | 12.97% | 1.70% | 16.81% | Upgrade
|
| EBITDA | 19,466 | 18,340 | 16,553 | 13,658 | 14,751 | 26,980 | Upgrade
|
| EBITDA Margin | 12.96% | 12.94% | 12.90% | 11.36% | 12.88% | 19.14% | Upgrade
|
| D&A For EBITDA | 5,688 | 5,172 | 4,952 | 4,321 | 4,079 | 4,251 | Upgrade
|
| EBIT | 13,778 | 13,168 | 11,601 | 9,337 | 10,672 | 22,729 | Upgrade
|
| EBIT Margin | 9.17% | 9.29% | 9.04% | 7.77% | 9.32% | 16.12% | Upgrade
|
| Effective Tax Rate | 26.57% | 24.78% | 24.75% | 23.87% | 22.66% | 27.70% | Upgrade
|
| Advertising Expenses | - | 28,214 | 23,549 | 25,406 | 24,725 | 28,631 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.